Drug Shortage Report for CLINDAMYCIN IV INFUSION
Report ID | 182824 |
Drug Identification Number | 02408511 |
Brand name | CLINDAMYCIN IV INFUSION |
Common or Proper name | CLINDAMYCIN |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | CLINDAMYCIN |
Strength(s) | 12MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 1ML |
ATC code | J01FF |
ATC description | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | |
Actual start date | 2023-01-31 |
Estimated end date | Unknown |
Actual end date | 2023-10-26 |
Shortage status | Resolved |
Updated date | 2023-10-27 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2023-10-27 | English | Compare |
v7 | 2023-10-26 | French | Compare |
v6 | 2023-10-26 | English | Compare |
v5 | 2023-02-01 | English | Compare |
v4 | 2023-01-31 | French | Compare |
v3 | 2023-01-31 | English | Compare |
v2 | 2023-01-31 | English | Compare |
v1 | 2023-01-31 | English | Compare |
Showing 1 to 8 of 8